Company begins roll out of innovative diabetes care HbA1c column system in Brazil Commercial leadership strengthened with key appointmentDUBLIN, ...

Zydus Lifesciences has announced the launch of its companion diagnostics portfolio with the introduction of Diasens and ...

A manufacturing problem in millions of Abbott glucose sensors has been tied to at least seven deaths and hundreds of injuries worldwide.

New data show that wearable neuromodulation can be used with CGMs without disrupting glucose accuracy or connectivity.

Historically, the medical devices world has been a highly proprietary industry, having long been characterized by the development of specialized, patented technologies that are closely guarded by ...

Study by Humana Healthcare Research and Yale School of Medicine researcher reveals significant increase in CGM usage, particularly among older adults with chronic health conditions. The study also ...

Zydus Lifesciences launches AI-powered CGM devices Diasens and GlucoLive for diabetes and CKD management, enabling continuous glucose tracking via the GoodFlip app.

Add Yahoo as a preferred source to see more of our stories on Google. (COLORADO SPRINGS) — A medical device for diabetes called the Dexcom is facing a national shortage that’s now leaving diabetics in ...

Zydus Lifesciences has introduced two artificial intelligence (AI)-enabled continuous glucose monitoring (CGM) devices, Diasens and GlucoLive, for real-time diabetes tracking.

About 3 million FreeStyle Libre 3 and FreeStyle Libre 3 Plus sensors manufactured by Abbott were recalled in November, because they might give wrong readings.

Patients alarmed after glucose monitors used by diabetics are recalled after links to 7 deaths - Abbott recalled certain sensors used in its FreeStyle Libre 3 and FreeStyle Libre 3 Plus systems, warni ...